✦ LIBER ✦

PCN17 COST OF MANAGING SIDE EFFECTS OF FIRST-LINE THERAPY FOR METASTATIC RENAL CELL CARCINOMA (MRCC) IN GERMANY, FRANCE, UK AND ITALY: BEVACIZUMAB (BEV) + INTERFERON-ALPHA2A COMPARED WITH SUNITINIB

✍ Scribed by GH Mickisch; B Escudier; M Gore; G Procopio; S Walzer; MJ Nuijten

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN16 COST OF MANAGING SIDE EFFECTS OF F

✍ GH Mickisch; B Escudier; M Gore; S Walzer; MJ Nuijten 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

PCN42 COSTS OF MANAGING ADVERSE EVENTS O

✍ F Carlos; J Ramirez; A Aguirre 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

PCN40 COST OF MANAGING ADVERSE EVENTS IN

✍ V Calderero; X García-Muro; J Puente; JM Trigo; AJ Castro; V Martín-Escudero; M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

7141 Costs of adverse events management

✍ Puente, J.; Calderero, V.; García-Muro, X.; Trigo, J.M.; Castro, A.J.; Martin-Es 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB